Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW -0.26% inched 0.07% higher to $121.02 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.18% rising 0.85% to 4,480.70 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.04% rising 0.68% to 34,814.39. This was the stock's second consecutive day of gains. Edwards Lifesciences Corp. closed $2.25 below its 52-week high ($123.27), which the company achieved on September 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +0.40% rose 0.82% to $131.65, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX -0.38% rose 0.36% to $45.01, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI -0.33% rose 1.95% to $243.88. Trading volume (1.7 M) remained 330,517 below its 50-day average volume of 2.0 M.